Jarkko Ylanko

2.2k total citations · 2 hit papers
13 papers, 1.6k citations indexed

About

Jarkko Ylanko is a scholar working on Molecular Biology, Biophysics and Oncology. According to data from OpenAlex, Jarkko Ylanko has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Biophysics and 3 papers in Oncology. Recurrent topics in Jarkko Ylanko's work include Cell Image Analysis Techniques (4 papers), DNA Repair Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). Jarkko Ylanko is often cited by papers focused on Cell Image Analysis Techniques (4 papers), DNA Repair Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). Jarkko Ylanko collaborates with scholars based in Canada, United States and United Kingdom. Jarkko Ylanko's co-authors include Daniel Durocher, Megan Mendez, Laurence Pelletier, Shinichiro Nakada, Jan Wildenhain, Stephanie Panier, Nadine K. Kolas, Richard Chahwan, Timothy M. Thomson and Stephen P. Jackson and has published in prestigious journals such as Science, Cell and Blood.

In The Last Decade

Jarkko Ylanko

13 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase

2007 719 citations Nadine K. Kolas, J. Ross Chapman et al. Science profile →
The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage

2009 599 citations Grant S. Stewart, Stephanie Panier et al. Cell profile →

Peers

Countries citing papers authored by Jarkko Ylanko

Since Specialization

Citations

This map shows the geographic impact of Jarkko Ylanko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarkko Ylanko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarkko Ylanko more than expected).

Fields of papers citing papers by Jarkko Ylanko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarkko Ylanko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarkko Ylanko. The network helps show where Jarkko Ylanko may publish in the future.

Co-authorship network of co-authors of Jarkko Ylanko

This figure shows the co-authorship network connecting the top 25 collaborators of Jarkko Ylanko. A scholar is included among the top collaborators of Jarkko Ylanko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarkko Ylanko. Jarkko Ylanko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels 2023 ·Biomaterials ·(unknown), Chang Xue, (unknown), (unknown), (unknown), Brigitte L. Thériault, David T. Uehling, (unknown), Rachel L. Peters, Kela Liu, Jianan Chen, Anne L. Martel, Martin J. Yaffe, Rima Al‐awar, Rashmi S. Goswami, Jarkko Ylanko, David W. Andrews, John Kuruvilla, Rob C. Laister, Molly S. Shoichet	10
2	Utilizing supervised machine learning to identify microglia and astrocytes in situ: implications for large-scale image analysis and quantification 2019 ·Journal of Neuroscience Methods ·(unknown), Jarkko Ylanko, Erica M. Weekman, Tina L. Beckett, David Andrews, JoAnne McLaurin	10
3	Improving drug discovery using image-based multiparametric analysis of the epigenetic landscape 2019 ·eLife ·Chen Farhy, Santosh Hariharan, Jarkko Ylanko, (unknown), Fu‐Yue Zeng, Ian Pass, Fernando Ugarte, E. Camilla Forsberg, Chun‐Teng Huang, David W. Andrews, Alexey V. Terskikh	18
4	Image‐Based Analysis of Protein Stability 2019 ·Cytometry Part A ·(unknown), Santosh Hariharan, Jason De Melo, Jarkko Ylanko, (unknown), Linda Z. Penn, David W. Andrews	2
5	Improved IRE1 and PERK Pathway Sensors for Multiplex Endoplasmic Reticulum Stress Assay Reveal Stress Response to Nuclear Dyes Used for Image Segmentation 2018 ·Assay and Drug Development Technologies ·(unknown), (unknown), Jarkko Ylanko, Ruth Rimokh, Germain Gillet, David W. Andrews	15
6	miRNA‐106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation 2018 ·Molecular Oncology ·Christianne Hoey, Jessica Ray, Jouhyun Jeon, Xiaoyong Huang, Samira Taeb, Jarkko Ylanko, David W. Andrews, Paul C. Boutros, Stanley K. Liu	41
7	High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells 2016 ·Blood ·Sina Oppermann, Jarkko Ylanko, Yonghong Shi, Santosh Hariharan, Christopher C. Oakes, Patrick M. Brauer, Juan Carlos Zúñiga‐Pflücker, Brian Leber, David Spaner, David W. Andrews	95
8	Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells 2016 ·Oncotarget ·Sina Oppermann, (unknown), Stephanie Tung, Yonghong Shi, (unknown), (unknown), Jarkko Ylanko, Brian Leber, David W. Andrews, David Spaner	12
9	A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image Analysis 2015 ·Assay and Drug Development Technologies ·Tony Collins, Jarkko Ylanko, Fei Geng, David W. Andrews	9
10	Abstract PR12: A genome-wide shRNA screen reveals that inhibiting kinases potentiates the anti-breast cancer activity of fluvastatin 2013 ·Molecular Cancer Therapeutics ·(unknown), Aleksandra A. Pandyra, Carolyn A. Goard, Elke Ericson, Kevin R. Brown, Jarkko Ylanko, David W. Andrews, Corey Nislow, Jason Moffat, Linda Z. Penn	1
11	The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage breakdown → 2009 ·Cell ·Grant S. Stewart, Stephanie Panier, Kelly Townsend, Abdallah Al-Hakim, Nadine K. Kolas, Edward S. Miller, Shinichiro Nakada, Jarkko Ylanko, (unknown), Megan Mendez, Ceri Oldreive, Jan Wildenhain, Andrea Tagliaferro, Laurence Pelletier, Nadine Taubenheim, Anne Durandy, Philip J. Byrd, Tatjana Stanković, A. Malcolm R. Taylor, Daniel Durocher	599
12	APLF (C2orf13) facilitates nonhomologous end-joining and undergoes ATM-dependent hyperphosphorylation following ionizing radiation 2008 ·DNA repair ·(unknown), Richard McCulloch, Jarkko Ylanko, Daniel Durocher, Christine Koch	74
13	Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase breakdown → 2007 ·Science ·Nadine K. Kolas, J. Ross Chapman, Shinichiro Nakada, Jarkko Ylanko, Richard Chahwan, (unknown), Stephanie Panier, Megan Mendez, Jan Wildenhain, Timothy M. Thomson, Laurence Pelletier, Stephen P. Jackson, Daniel Durocher	719

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact